Imeglimin Beneficial As Add-On to Metformin in T2DM

For patients with type 2 diabetes inadequately controlled by metformin alone, addition of the new oral anti-diabetes agent imeglimin improves glycemic control with good tolerability and safety, according to a study published online Nov. 16 in Diabetes Care.

Read more

Posted in Type II Drugs